These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23500665)

  • 61. Green Synthesis of Silymarin-Chitosan Nanoparticles as a New Nano Formulation with Enhanced Anti-Fibrotic Effects against Liver Fibrosis.
    Abdullah AS; Sayed IETE; El-Torgoman AMA; Kalam A; Wageh S; Kamel MA
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628233
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations.
    Zorkina Y; Abramova O; Ushakova V; Morozova A; Zubkov E; Valikhov M; Melnikov P; Majouga A; Chekhonin V
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33202839
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metal nanoparticles synthesis through natural phenolic acids.
    Amini SM; Akbari A
    IET Nanobiotechnol; 2019 Oct; 13(8):771-777. PubMed ID: 31625516
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Targeting silymarin for improved hepatoprotective activity through chitosan nanoparticles.
    Gupta S; Singh SK; Girotra P
    Int J Pharm Investig; 2014 Oct; 4(4):156-63. PubMed ID: 25426436
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for improved antioxidant and antidepressant-like activity.
    Nagpal K; Singh SK; Mishra DN
    Drug Deliv; 2012 Nov; 19(8):378-91. PubMed ID: 23173579
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for protection against scopolamine-induced amnesia.
    Nagpal K; Singh SK; Mishra DN
    Drug Deliv; 2013; 20(3-4):112-9. PubMed ID: 23651033
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Antianxiety-like activity of gallic acid in unstressed and stressed mice: possible involvement of nitriergic system.
    Dhingra D; Chhillar R; Gupta A
    Neurochem Res; 2012 Mar; 37(3):487-94. PubMed ID: 22033862
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Influence of the formulation on the maximum tolerated doses of brain targeted nanoparticles of gallic acid by oral administration in Wistar rats.
    Nagpal K; Singh SK; Mishra D
    J Pharm Pharmacol; 2013 Dec; 65(12):1757-64. PubMed ID: 24236986
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety.
    Nagpal K; Singh SK; Mishra DN
    Int J Biol Macromol; 2013 Aug; 59():72-83. PubMed ID: 23597710
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Optimization of brain targeted gallic acid nanoparticles for improved antianxiety-like activity.
    Nagpal K; Singh SK; Mishra DN
    Int J Biol Macromol; 2013 Jun; 57():83-91. PubMed ID: 23500665
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.